The Problem of Establishing Standards of Care in an Uncommon Malignancy: Brachytherapy for Invasive Penile Carcinoma

In this issue of the International Journal of Radiation Oncology • Biology • Physics, Escande et al (1) report a phenomenal single-institution experience with interstitial 192Ir low-dose-rate or pulsed-dose-rate brachytherapy for squamous cell carcinoma of the glans penis. Their experience, which spans 45 years and involves more than 200 patients with a median follow-up of more than 10 years, indisputably establishes interstitial brachytherapy as an effective penile-sparing modality for squamous cell carcinoma of the glans.

http://ift.tt/2w5FQtd